Literature DB >> 2100275

Effect of chronic clonidine treatment on urinary growth hormone excretion and linear growth in children with short stature.

A Sanmartí1, A Lucas, M L Granada, I Salinas, J L Reverter, J M Cuatrecasas, M Foz, L Audi.   

Abstract

Eleven prepubertal children with short stature were treated with clonidine (0.15 mg/m2 daily) for a period of 1 year. The effect of this drug was evaluated on both clinical (growth velocity, height standard deviation scores for chronological age and bone age) and hormonal (urinary growth hormone excretion and insulin-like growth factor I) parameters. Our study shows that long-term clonidine administration in children with short stature did not result in significant differences in growth velocity, height standard deviation scores for chronological age and bone age, insulin-like growth factor I or in urinary growth hormone excretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2100275     DOI: 10.1159/000181824

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  2 in total

1.  Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine.

Authors:  F Orio; N Padovano; L Cinquanta; A Colao; B Merola; S Longobardi; E Rossi; V Esposito; F Orio; G Lombardi
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

2.  Increased Secretion of Endogenous GH after Treatment with an Intranasal GH-releasing Peptide-2 Spray Does Not Promote Growth in Short Children with GH Deficiency.

Authors:  Toshiaki Tanaka; Yukihiro Hasegawa; Susumu Yokoya; Yoshikazu Nishi
Journal:  Clin Pediatr Endocrinol       Date:  2014-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.